CIC
BDSX icon

Carnegie Investment Counsel’s Biodesix BDSX Stock Holding History

Carnegie Investment Counsel’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-500
Closed -$2.82K – 555
2025
Q2 		$2.82K Buy
+500
New +$4.04K ﹤0.01% 541

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Carnegie Investment Counsel's BDSX Position: Q3 2025 in Review

Carnegie Investment Counsel sold out of Biodesix (BDSX) in Q3 2025, closing a stake of 500 shares — an estimated $2.82K sold.

Carnegie Investment Counsel first reported a position in BDSX in Q2 2025 and held it in 1 quarter. The position peaked at $2.82K in Q2 2025. 26 funds tracked by Wall St. Rank hold BDSX as of Q3 2025.

  • Carnegie Investment Counsel reported no remaining Biodesix position as of Q3 2025 after selling out during the quarter.
  • Carnegie Investment Counsel sold 500 Biodesix shares in Q3 2025, an estimated $2.82K.
  • Carnegie Investment Counsel first reported a position in Biodesix in Q2 2025 and held it in 1 quarter.
  • Carnegie Investment Counsel's Biodesix position peaked at $2.82K in Q2 2025.
  • 26 funds tracked by Wall St. Rank held Biodesix as of Q3 2025.

Based on Carnegie Investment Counsel's 13F filing for Q3 2025, filed 16 Oct 2025.